► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
David Crow reports from the FT US Healthcare and Life Sciences Conference in New York and asks pharmaceutical industry leaders whether a revolution in drug development could be hampered by a pricing backlash.
► FT Business: http://bit.ly/1KUK08s
► FT Global Economy: http://bit.ly/1J5mmqH
► Budget 2015: Science relies on ringfencing: http://bit.ly/1KPrSQF
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
